Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
NCT ID: NCT06987552
Last Updated: 2025-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
25 participants
INTERVENTIONAL
2024-12-24
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Performance of da Vinci SP System on Extraperitoneal Approach Radical Prostatectomy
NCT05403190
A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries
NCT06181942
Prospective Investigation of Robotic Single-port System
NCT02136121
MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology
NCT04404738
Prospective Study on the Use of the Da Vinci SP System in Urological Surgery
NCT07032194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Operation of focus procedure with da Vinci SP Surgery System
Single-Port Robot-Assisted Surgery Using Da Vinci SP Surgical System for Patients with Upper Tract Urothelial Cancer
Da Vinci SP Surgical System
Da Vinci SP Surgical System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Da Vinci SP Surgical System
Da Vinci SP Surgical System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically or cytologically diagnosed upper tract urothelial cancer
* Fitting indications of radical nephroureterectomy and ipsilateral bladder cuff resection, and deemed feasible for robotic surgery
* ASA physical status classification 1-2 and adequate organ function
* Patients willing and able to comply with study protocol requirements and follow-up
* With informed consent
Exclusion Criteria
* Distant metastasis of cancer
* BMI ≥30 or BMI \<18.5
* Unable to tolerate lateral decubitus or Trendelenburg position (relative contra-indication)
* Severe adhesion due to prior abdominopelvic surgery (relative contra-indication)
* Previous radiation treatment to the pelvic area
* Active infectious disease
* Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic interventions, such as: severe heart disease (NYHA functional class III-IV) or severe lung disease (GOLD Group C-D)
* Cannot follow trial-required procedures
* Concomitant systemic or pelvic disease that increases the risk of surgery
* Long-term use of anti-coagulant(s)
* Patients with coagulopathy
* Emergency surgery
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Intuitive Surgical
INDUSTRY
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shih-Chieh Chueh
Role: STUDY_DIRECTOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Taiwan National Taiwan University Hospital, DIRECTOR
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
SHIH-CHIEH CHUEH
Role: primary
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202409016DIPD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.